Lamotrigine inhibits TRESK regulated by G-protein coupled receptor agonists

Biochemical and Biophysical Research Communications

Volumn 367, Issue 3, 2008, Pages 609-615

  Kang, Dawon ^a   Kim, Gyu Tae ^a   Kim, Eun Jin ^a   La, Jun Ho ^a   Lee, Jeong Soon ^a   Lee, Eun Shin ^a   Park, Jae Yong ^a   Hong, Seong Geun ^a   Han, Jaehee ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

G protein coupled receptor; Ganglia; Lamotrigine; Tandem pore domain potassium channel

Indexed keywords

AMINOPYRIDINE; APAMIN; ARACHIDONIC ACID; BUPIVACAINE; CALCIMYCIN; FLUOXETINE; G PROTEIN COUPLED RECEPTOR; GABAPENTIN; IONOMYCIN; LAMOTRIGINE; POTASSIUM CHANNEL; PREGABALIN; PROTEIN TRESK; QUINIDINE; TETRYLAMMONIUM; UNCLASSIFIED DRUG; ZINC;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG INHIBITION; ENZYME ACTIVITY; NERVE CELL EXCITABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; SPINAL GANGLION;

ANALGESICS; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; GANGLIA, SPINAL; GLUTAMIC ACID; MICE; NEURONS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; TRIAZINES;

EID: 38749093319     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.008     Document Type: Article

References (23)

1. + channels in dorsal root ganglion neurons. Am. J. Physiol. Cell. Physiol. 291 (2006) C138-C146
2. + channels constitute a significant component of background potassium currents in murine DRG neurones. J. Physiol. (2007)
3. + channel, TRESK, is localized in the spinal cord. J. Biol. Chem. 278 (2003) 27406-27412
4. + channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin. J. Biol. Chem. 279 (2004) 18550-18558
5. + channel family. J. Biol. Chem. 279 (2004) 28063-28070
6. + channel TASK-2 (KCNK5). J. Pharmacol. Exp. Ther. 306 (2003) 84-92
7. Kindler C.H., and Yost C.S. Two-pore domain potassium channels: new sites of local anesthetic action and toxicity. Reg. Anesth. Pain Med. 30 (2005) 260-274
8. + channels. Mol. Pharmacol. 69 (2006) 1024-1032
9. 2P channel TRESK. Anesth. Analg. 101 (2005) 1042-1049 table of contents
10. Kang D., Han J., and Kim D. Mechanism of Inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor. Am. J. Physiol. Cell Physiol. (2006)
11. 2+ from the same store in cultured DRG neurones. Cell Calcium 26 (1999) 139-148
12. Tata A.M., Tripiciano A., Filippini A., Biagioni S., and Augusti-Tocco G. Muscarinic receptors modulate intracellular calcium level in chick sensory neurons. Brain Res. 866 (2000) 65-72
13. Tata A.M., Vilaro M.T., and Mengod G. Muscarinic receptor subtypes expression in rat and chick dorsal root ganglia. Brain Res. Mol. Brain Res. 82 (2000) 1-10
14. + channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin. J. Biol. Chem. (2004)
15. + channel, TRESK. J. Biol. Chem. 281 (2006) 14677-14682
16. + channels. EMBO J. 22 (2003) 5403-5411
17. Fioretti B., Catacuzzeno L., Tata A.M., and Franciolini F. Histamine activates a background, arachidonic acid-sensitive K channel in embryonic chick dorsal root ganglion neurons. Neuroscience 125 (2004) 119-127
18. King J.C. Therapeutic options for neuropathic pain. J. Trauma 62 (2007) S7
19. Kennard L.E., Chumbley J.R., Ranatunga K.M., Armstrong S.J., Veale E.L., and Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br. J. Pharmacol. 144 (2005) 821-829
20. Thummler S., Duprat F., and Lazdunski M. Antipsychotics inhibit TREK but not TRAAK channels. Biochem. Biophys. Res. Commun. 354 (2007) 284-289
21. Meadows H.J., Chapman C.G., Duckworth D.M., Kelsell R.E., Murdock P.R., Nasir S., Rennie G., and Randall A.D. The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK. Brain Res. 892 (2001) 94-101
22. Coderre T.J., Kumar N., Lefebvre C.D., and Yu J.S. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J. Neurochem. 100 (2007) 1289-1299
23. Cruccu G. Treatment of painful neuropathy. Curr. Opin. Neurol. 20 (2007) 531-535